tiprankstipranks
Advertisement
Advertisement

JP:4599 Stock Latest News

StemRIM to Record AMED Subsidy as Non-Operating Income for Gene Therapy Project
Company AnnouncementsStemRIM to Record AMED Subsidy as Non-Operating Income for Gene Therapy Project
5d ago
4599
StemRIM Wins Australian Patent for Redasemtide Cartilage Disorder Therapy
PremiumCompany Announcements
StemRIM Wins Australian Patent for Redasemtide Cartilage Disorder Therapy
7d ago
4599
StemRIM Wins Russian Patent to Expand Redasemtide Use in Fatty Liver and NASH
PremiumCompany Announcements
StemRIM Wins Russian Patent to Expand Redasemtide Use in Fatty Liver and NASH
8d ago
4599
StemRIM posts continued loss but secures R&D runway through 2028
PremiumCompany Announcements
StemRIM posts continued loss but secures R&D runway through 2028
14d ago
4599
StemRIM Plans Tax-Efficient Capital Reduction Ahead of July Extraordinary Meeting
PremiumCompany Announcements
StemRIM Plans Tax-Efficient Capital Reduction Ahead of July Extraordinary Meeting
1M ago
4599
StemRIM Highlights Shionogi’s Timelines for Regenerative Drug Redasemtide in DEB and Stroke
PremiumCompany AnnouncementsStemRIM Highlights Shionogi’s Timelines for Regenerative Drug Redasemtide in DEB and Stroke
1M ago
4599
StemRIM Completes Enrollment in Early-Stage Redasemtide Trial for Ischemic Cardiomyopathy
Premium
Company Announcements
StemRIM Completes Enrollment in Early-Stage Redasemtide Trial for Ischemic Cardiomyopathy
2M ago
4599
StemRIM Unveils Midterm FY2026 Results and R&D Progress in Regenerative Medicine
Premium
Company Announcements
StemRIM Unveils Midterm FY2026 Results and R&D Progress in Regenerative Medicine
3M ago
4599
StemRIM narrows interim loss as it ramps R&D on regenerative drug pipeline
PremiumCompany Announcements
StemRIM narrows interim loss as it ramps R&D on regenerative drug pipeline
3M ago
4599
StemRIM Wins Key Patent on Gene Therapy SR-GT1 for Dystrophic Epidermolysis Bullosa
PremiumCompany Announcements
StemRIM Wins Key Patent on Gene Therapy SR-GT1 for Dystrophic Epidermolysis Bullosa
4M ago
4599
StemRIM Wins Canadian Patent for Redasemtide Use in Cartilage Disorders
PremiumCompany Announcements
StemRIM Wins Canadian Patent for Redasemtide Use in Cartilage Disorders
4M ago
4599
StemRIM Completes Global Phase 2b Enrollment for Stroke Drug Redasemtide
PremiumCompany Announcements
StemRIM Completes Global Phase 2b Enrollment for Stroke Drug Redasemtide
6M ago
4599
StemRIM Secures Patent for Innovative Fatty Liver and NASH Therapy in Japan
PremiumCompany AnnouncementsStemRIM Secures Patent for Innovative Fatty Liver and NASH Therapy in Japan
6M ago
4599
StemRIM Inc. Reports Q3 2025 Financial Results Amid Ongoing R&D Investments
Premium
Company Announcements
StemRIM Inc. Reports Q3 2025 Financial Results Amid Ongoing R&D Investments
7M ago
4599
StemRIM Completes New Share Issuance for Stock Compensation
Premium
Company Announcements
StemRIM Completes New Share Issuance for Stock Compensation
7M ago
4599
StemRIM Inc. Forms Voluntary Compensation Committee to Enhance Governance
PremiumCompany Announcements
StemRIM Inc. Forms Voluntary Compensation Committee to Enhance Governance
7M ago
4599
StemRIM Inc. Unveils Revolutionary Regenerative Medicine Plan
PremiumCompany Announcements
StemRIM Inc. Unveils Revolutionary Regenerative Medicine Plan
7M ago
4599
StemRIM Inc. Issues New Shares for Restricted Stock Remuneration
PremiumCompany Announcements
StemRIM Inc. Issues New Shares for Restricted Stock Remuneration
7M ago
4599
StemRIM Secures Patent for Innovative Gene Therapy Targeting Skin Disorder
PremiumCompany Announcements
StemRIM Secures Patent for Innovative Gene Therapy Targeting Skin Disorder
8M ago
4599
StemRIM Secures US Patent for Psoriasis Treatment
PremiumCompany AnnouncementsStemRIM Secures US Patent for Psoriasis Treatment
9M ago
4599
StemRIM Inc. Issues Stock Options to Enhance Stakeholder Engagement
Premium
Company Announcements
StemRIM Inc. Issues Stock Options to Enhance Stakeholder Engagement
9M ago
4599
StemRIM Inc. Proposes Stock Options to Boost Workforce Morale
Premium
Company Announcements
StemRIM Inc. Proposes Stock Options to Boost Workforce Morale
9M ago
4599

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >